Dr Reddys Laboratories Q2 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,209
-4.90 (-0.40%)
-4.90 (-0.40%)Volume92.17 K
Updated: Mon 25 Nov, 2024 | 15:53:03
NSE
1,209.3-5.15 (-0.42%)
-5.15 (-0.42%)Volume3.28 M
Updated: Mon 25 Nov, 2024 | 15:40:52
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹8,038.20 Cr.(4.45%)
- Operating Profit₹1,679.50 Cr.(-3.99%)
- Profit After Tax₹1,255.70 Cr.(-9.82%)
- Operating Margin20.89%(-16.69%)
Note: Comparison is on YoY basis
Quarterly - Dr Reddys Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 8,038.20 | 6,757.90 | -% | 6,902.60 | -% |
| Selling/ General/ Admin Expenses Total | 3,502.60 | 2,757.10 | -% | 2,885.80 | -% |
| Depreciation/ Amortization | 397.00 | 353.30 | -% | 375.50 | -% |
| Total Operating Expense | 6,358.70 | 4,995.10 | -% | 5,171.40 | -% |
| Operating Income | 1,679.50 | 1,762.80 | -% | 1,731.20 | -% |
| Net Income Before Taxes | 1,917.40 | 1,850.00 | -% | 1,916.70 | -% |
| Net Income | 1,255.70 | 1,405.00 | -% | 1,482.20 | -% |
| Diluted Normalized EPS | 15.85 | 81.95 | -% | 84.60 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST